Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
AerCap
AER
$23.2B
| $7.53M | 0.01% |
196,801
-1,496,143
| -88% | -$66.1M |
|
1102
Anika Therapeutics
ANIK
$286M
| $7.51M | 0.01% |
236,089
+111,865
| +90% | +$3.9M |
|
|
ALEX
1103
DELISTED
Alexander & Baldwin
ALEX
| $7.5M | 0.01% |
218,497
-16,869
| -7% | -$616K |
|
|
CNR
1104
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $7.46M | 0.01% |
705,983
+414,799
| +142% | +$5.08M |
|
1105
El Pollo Loco
LOCO
$484M
| $7.43M | 0.01% |
689,137
+567,403
| +466% | +$8.87M |
|
|
PMCS
1106
DELISTED
P M C SIERRA INC
PMCS
| $7.41M | 0.01% |
1,094,502
+129,673
| +13% | +$881K |
|
1107
Saia
SAIA
$9.32B
| $7.39M | 0.01% |
+238,658
| New | +$9.11M |
|
1108
PUT
Broadcom
AVGO
$1.71T
| $7.38M | 0.01% |
590,000
-250,000
| -30% | -$3.16M |
|
|
CALY
1109
Callaway Golf Company
CALY
$2.82B
| $7.37M | 0.01% |
883,150
+651,683
| +282% | +$5.71M |
|
1110
CALL
Lazard
LAZ
$4.29B
| $7.36M | 0.01% |
+170,000
| New | +$8.76M |
|
1111
Pegasystems
PEGA
$5.64B
| $7.35M | 0.01% |
597,574
+386,386
| +183% | +$4.78M |
|
|
WPZ
1112
DELISTED
Williams Partners L.P.
WPZ
| $7.34M | 0.01% |
230,000
+140,000
| +156% | +$5.86M |
|
1113
Cigna
CI
$74.1B
| $7.34M | 0.01% |
54,370
-74,385
| -58% | -$10.8M |
|
1114
Dolby
DLB
$6.19B
| $7.32M | 0.01% |
224,622
-37,253
| -14% | -$1.27M |
|
|
LTRPA
1115
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $7.31M | 0.01% |
329,807
-2,853
| -0.9% | -$79K |
|
1116
Ionis Pharmaceuticals
IONS
$10.3B
| $7.31M | 0.01% |
180,814
-187,242
| -51% | -$9.69M |
|
|
XXIA
1117
DELISTED
Ixia
XXIA
| $7.3M | 0.01% |
504,003
+54,039
| +12% | +$770K |
|
1118
Methode Electronics
MEI
$498M
| $7.3M | 0.01% |
+228,878
| New | +$6.45M |
|
1119
ABM Industries
ABM
$2.75B
| $7.29M | 0.01% |
267,118
+62,226
| +30% | +$1.97M |
|
1120
Century Aluminum
CENX
$4.32B
| $7.27M | 0.01% |
1,581,139
+740,374
| +88% | +$5.17M |
|
|
CGI
1121
DELISTED
Celadon Group Inc
CGI
| $7.27M | 0.01% |
453,873
+143,563
| +46% | +$2.84M |
|
1122
iShares US Real Estate ETF
IYR
$4.67B
| $7.25M | 0.01% |
102,260
+18,982
| +23% | +$1.38M |
|
1123
Masco
MAS
$14.4B
| $7.25M | 0.01% |
287,879
-809,822
| -74% | -$20.8M |
|
|
BIG
1124
DELISTED
Big Lots, Inc.
BIG
| $7.25M | 0.01% |
151,206
-337,660
| -69% | -$15M |
|
1125
Kforce
KFRC
$1.03B
| $7.24M | 0.01% |
275,533
+114,425
| +71% | +$2.92M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.